Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.84% | 166.17 | 0.7% | $1113.67m | |
| PFE | Pfizer Inc. | -1.73% | 48.42 | 0.9% | $897.84m | |
| LLY | Eli Lilly & Co. | -0.46% | 315.35 | 1.1% | $807.10m | |
| MRK | Merck & Co., Inc. | -0.05% | 91.00 | 0.7% | $787.49m | |
| ABBV | AbbVie, Inc. | -0.81% | 140.29 | 1.9% | $785.78m | |
| BMY | Bristol-Myers Squibb Co. | -0.98% | 73.83 | 1.0% | $632.35m | |
| SIGA | SIGA Technologies, Inc. | -6.38% | 23.19 | 0.0% | $437.14m | |
| AZN | AstraZeneca Plc | -0.34% | 66.20 | 1.0% | $362.85m | |
| GBT | Global Blood Therapeutics, Inc. | 0.13% | 67.09 | 5.6% | $345.26m | |
| GSK | GSK Plc | -1.13% | 33.92 | 0.3% | $285.63m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -0.19% | 222.71 | 8.2% | $269.54m | |
| HZNP | Horizon Therapeutics Plc | -1.81% | 60.61 | 5.4% | $218.06m | |
| CCXI | ChemoCentryx, Inc. | 0.22% | 50.89 | 2.9% | $208.84m | |
| KRTX | Karuna Therapeutics, Inc. | 0.03% | 261.31 | 0.0% | $204.30m | |
| VERU | Veru, Inc. | -20.12% | 19.00 | 0.0% | $194.94m |
Company Profile
Repligen Corp. provides bioprocessing technologies and solutions used in the process of manufacturing biologic drugs. It serves through the following product lines: Chromatography, Filtration, Process Analytics, and Proteins. The Chromatography product includes a range of products used in the downstream purification and quality control of biological drugs. The Filtration products offer a number of advantages to manufacturers of biologic drugs at volumes that span from pilot studies to clinical and commercial-scale production. The Process Analytics products complement and support filtration, chromatography and proteins in-line absorbance measurements allowing for the determination of protein concentration in filtration, chromatography formulation and fill-finish applications. The Proteins product franchise is represented by Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification of virtually all mAb-based drugs on the market. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.